Effectiveness of Nonadjuvanted Monovalent Influenza A(H1N1)pdm09 Vaccines for Preventing Reverse Transcription Polymerase Chain Reaction–Confirmed Pandemic Influenza Hospitalizations: Case-Control Study of Children and Adults at 10 US Influenza Surveillance Network Sites
Year: 2013
Type: article
Study design: Observational Study
Abstract: During 2009-2010, we examined 217 patients hospitalized with laboratory-confirmed pandemic influenza in 9 Influenza Hospitalization Surveillance Network sites and 413 age- and community-matched controls and found that a single dose of monovalent nonadjuvanted influenza A(H1N1)pdm09 vaccine was 50% (95% confidence interval, 13%-71%) effective in preventing hospitalization associated with A(H1N1)pdm09 virus infection.
Source: Clinical Infectious Diseases
DOI: 10.1093/cid/cit551
Authors: Mark G. Thompson, Leslie Z. Sokolow, Olivia Almendares, Kyle Openo, Monica M. Farley, James Meek, Julie Ray, Pamala Daily Kirley, Arthur Reingold, Deborah Aragon, Emily Hancock, Joan Baumbach, William Schaffner, Ruth Lynfield, Pat Ryan, Maya Monroe, Po-Yung Cheng, Alicia M. Fry, David K. Shay
Institutions: Centers for Disease Control and Prevention, Centers for Disease Control and Prevention, Centers for Disease Control and Prevention, Battelle, Atlanta Research and Education Foundation, Atlanta VA Medical Center, Emory University, University of California, Berkeley, Colorado Department of Public Health and Environment, Vanderbilt University, Tennessee Department of Health, Minnesota Department of Health, Maryland Department of Health
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: CONNECTICUT EMERGING INFECTIONS PROGRAM, EMERGING INFECTIONS PROGRAM, MARYLAND EMERGING INFECTIONS PROGRAM, EMERGING INFECTIONS PROGRAM, EMERGING INFECTIONS PROGRAMS, CALIFORNIA EMERGING INFECTIONS PROGRAM, COLORADO EMERGING INFECTIONS PROGRAM, EMERGING INFECTIONS PROGRAM, EMERGING INFECTIONS PROGRAM
OpenAlex ID: W2167679892